The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis

Sophia M. Naz, Tracey M. Farragher, Diane K. Bunn, Deborah P. M. Symmons, Ian N. Bruce

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Objective To investigate the influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis (IP), and to examine predictors of mortality in relation to disease duration.Methods From 1990 to 1994, patients with recent-onset IP were registered with the Norfolk Arthritis Register (NOAR) and followed up prospectively. Standardized mortality ratios (SMRs) were calculated for all-cause and cardiovascular disease (CVD) mortality and for those who were younger than age 55 years at disease onset and for the first 5 and 10 years of followup. Cox proportional hazards models were developed to assess predictors of early and later mortality.Results Of 1,098 patients, 224 (20%) had died by the end of 2004. All-cause and CVD mortality were increased in rheumatoid factor (RF)–positive patients and in this subgroup, CVD mortality was increased at both early and later followup (SMR 5-year followup 1.93 [95% confidence interval 1.08–3.19]; SMR 10-year followup 2.00 [95% confidence interval 1.37–2.80]). CVD mortality was highest in seropositive patients
Original languageEnglish
Pages (from-to)985-989
Number of pages5
JournalArthritis & Rheumatism
Volume58
Issue number4
DOIs
Publication statusPublished - Apr 2008

Cite this